| Serial Number | 79222695 |
| Word Mark | R&D BIONICE |
| Filing Date | Monday, April 17, 2017 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, August 6, 2018 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical and veterinary active ingredients for treating diseases of the alimentary tract and metabolism; pharmaceutical and veterinary active ingredients for treating diseases of the cardiovascular system; pharmaceutical and veterinary active ingredients for treatment of diseases of the skin; pharmaceutical and veterinary active ingredients for treatment of diseases of the respiratory system; pharmaceutical and veterinary active ingredients for treating diseases of the musculoskeletal system; pharmaceutical and veterinary active ingredients for treating diseases of the nervous system; pharmaceutical preparations, namely, antidepressants; sanitary products for medical use; dietetic food and substances for medical or veterinary use; disinfectants; products for destroying vermin; fungicides, herbicides; chemical preparations for pharmaceutical and veterinary use, namely, for treating diseases of the cardiovascular, respiratory, musculoskeletal and the nervous system; hormones for medical use; steroids; antihistamines |
| Description of the Colors Claimed | It consists in the designation "R&D BioNice". The letters "R&D" and "Bio" are represented in blue, while "Nice" appears in gray. |
| Goods and Services | Custom manufacture of pharmaceutical and veterinary active ingredients for treating diseases of the alimentary tract and metabolism, diseases of the cardiovascular system, diseases of the skin, diseases of the respiratory system, diseases of the musculoskeletal system and diseases of the nervous system; custom manufacture of chemico-pharmaceutical preparations, namely, antidepressants; custom manufacture of sanitary products for medical use; custom manufacture of dietetic food and substances for medical or veterinary use; custom manufacture of disinfectants, products for destroying vermin, fungicides and herbicides; custom manufacture of chemical preparations for pharmaceutical and veterinary use, namely, for treating diseases of the cardiovascular, respiratory, musculoskeletal and the nervous system; custom manufacture of hormones for medical use, steroids and antihistamines; processing of pharmaceutical and chemical products |
| Indication of Colors claimed | The color(s) blue and gray is/are claimed as a feature of the mark. |
| Goods and Services | Pharmaceutical research and development; providing medical research information; providing veterinary research information; conducting clinical trials for others relating to pharmaceutical products; laboratory services, namely, analytical laboratory services; analysis and evaluation of product development; design and development of new technology for others in the field of biotechnology, pharmacy and chemistry; provision of information, advice and consultancy relating to all the aforementioned services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 15, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 15, 2017 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 15, 2017 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CURIA SPAIN, S.A.U. |
| Party Type | 12 - New Owner Before Publication |
| Legal Entity Type | 98 - Unknown |
| Address | ES |
| Party Name | CRYSTAL PHARMA, S.A.U. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 99 - Other |
| Address | ES |
| Party Name | BIONICE, S.L.U. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | ES |
| Event Date | Event Description |
| Thursday, December 7, 2017 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Wednesday, December 13, 2017 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Friday, December 15, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, December 15, 2017 | ASSIGNED TO EXAMINER |
| Friday, December 15, 2017 | NON-FINAL ACTION WRITTEN |
| Saturday, December 16, 2017 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, December 19, 2017 | APPLICATION FILING RECEIPT MAILED |
| Saturday, January 6, 2018 | REFUSAL PROCESSED BY MPU |
| Saturday, January 6, 2018 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, January 27, 2018 | REFUSAL PROCESSED BY IB |
| Monday, August 6, 2018 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, August 6, 2018 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Wednesday, May 8, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, May 8, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Thursday, May 23, 2019 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, May 24, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, August 6, 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, August 6, 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, August 23, 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, February 12, 2021 | CHANGE OF OWNER RECEIVED FROM IB |
| Thursday, February 5, 2026 | CHANGE OF NAME/ADDRESS REC'D FROM IB |